Trial intelligence / Profile preview

Calcifediol in COVID-19

NCT04366908Phase 2Completed

Sponsor
Maimónides Institute of Biomedical Research of Córdoba
Start
May 2020
Primary completion
Apr 2022
Countries
1
01

Overview

A Phase 2 trial of calcifediol in coronavirus disease 2019 (COVID-19), sponsored by Maimónides Institute of Biomedical Research of Córdoba. Started May 2020; status: completed.

02

Drugs

calcifediol
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04366908.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04366908.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call